This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Real World Evidence Solutions Market

Market Insights on Real World Evidence Solutions covering sales outlook, demand forecast & up-to-date key trends

Real World Evidence Solutions Market by Component, Application, End-user & Region - Forecast 2022 - 2032

Real World Evidence Solutions Market Snapshot (2022-2032)

[250 Pages Report] According to newly released Global Real World Evidence Solutions market analysis report by Future Market Insights, the market was valued at US$ 39.2 Bn in 2021 and is expected to rise at a CAGR of 10% from 2022 to 2032. While comparing to its historical CAGR of only 8.6%, the market is predicted to rise significantly. During the projected period, the market is expected to create an absolute dollar opportunity of US$ 67.2 Bn. Owing to the support from regulatory bodies and increased R&D expenditure by global competitors, the global market for Real World Evidence Solutions is likely to be valued at US$ 110 Bn by the end of 2032.

The key reasons driving the growth of the global Real World Evidence Solutions Market are the switch from volume-based to value-based care, favourable government policies, expansion in R&D spending and rising focus on end-to-end RWE services. Additionally, rising focus on personalised healthcare, increased incidence of chronic diseases, growing geriatric population and regulatory support for the adoption of RWE solutions are projected to fuel market growth. The U.S. market constitutes a majority share of nearly 3% in the global market and is expected to grow at a CAGR of 11.2% during the forecast period.

Attributes

Details

Real World Evidence Solutions Market CAGR (2022-2032)

10%

Real World Evidence Solutions Market Size (2022)

US$ 42.8 Bn

Real World Evidence Solutions Market Size (2032)

US$ 109 Bn

Customize this Report

Let us know your requirement to get
100% FREE customization

Revenue of Real-World Evidence Solutions Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the publications released by Future Market Insights - market research and competitive intelligence provider on Real World Evidence Solutions Market, the market is presently valued at US$ 39.2 Bn. During the forecast period, the Global Market for Real World Evidence Solutions will grow at a CAGR of 10% as compared to the historical CAGR of just 8.6%. The market is estimated to offer an absolute dollar opportunity of US$ 67.2 Bn in the next 10 years and is likely to hit the valuation of US$110 Bn by 2032. Collaboration among health organisations for leveraging RWE data to improve clinical trial efficiency and monitoring drug safety is driving the market.

  • The Real World Evidence Solutions Market was valued at US$ 39.2 Bn in 2021 and is expected to reach the valuation of US$ 42.8 Bn by the end of 2022.
  • The Global Market is estimated to provide an absolute dollar opportunity of US$ 67.2 Bn in the upcoming 10 years.
  • During 2017-2021, the Real World Evidence Solutions market grew at a CAGR of 8.6%.
  • The market is expected to grow at a CAGR of 10% during the forecasted period (2022-2032) to reach the valuation of US$ 110 Bn by the end of 2032.
  • As per the Future Market Insights estimates, the Global Real Evidence Solutions market will grow 2.6X during the period between 2022 and 2032.
  • The Services segment is expected to be a top component growing at a CAGR of 10.4% during the forecast period as compared to the historical CAGR of just 8.5%.
  • Drug Development and Approvals are likely to remain the top application with a CAGR of 10% as compared to the historical CAGR of 9.5%.
  • The U.S. market constitutes a majority share of 30% in the Global Real Evidence Solutions Market and is expected to grow at a CAGR of 11.2% during the forecasted period.

What are the major factors driving the growth of the Real World Evidence Solutions Market?

The rise in chronic illness incidence, the switch from volume to value-based care, the expanding focus on personalized healthcare and the growing geriatric population are projected to drive the growth of the Real World Evidence Solutions Market. Regulatory bodies' encouragement for the use of Real-world evidence (RWE) solutions is expected to drive industry growth. The RWE data has been pooled by the major health organizations to improve clinical trial efficiency and maintain risk-benefit data. As a result, market growth is projected to be aided by favorable government initiatives.

RWE can often provide a complete perspective that can’t be provided in traditional clinical trials. Observational research that is well-designed can reveal hidden characteristics of diseases, benefiting researchers and policymakers in improving care delivery systems and raising public awareness regarding the disease. The Patient centric medication was promoted with the adoption of RWE based developments with more enhanced design and clinical studies. Adoption of real-world evidence makes information more accessible and reduces barriers, while also allowing for a greater knowledge of how medicine is utilized in practice.

Many firms are experimenting with novel techniques to cut clinical trial expenses and avoid drug development barriers to speed up the drug development process. Furthermore, drug development delays are projected to stimulate market expansion in terms of switching from clinical trials to less time-consuming RWE Solutions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What was the impact of the Covid-19 pandemic on the Global Real World Evidence Solutions Market?

The pandemic challenged earlier forecasts of roughly 8.6% YoY growth, resulting in a drop in the year-on-year growth rate from 2019 to 2020. With the onset of the Global pandemic, key market players began to endure widespread business disruptions as a result of the pandemic, which hampered routine company operations. The businesses were unable to conduct on-site surveillance or provide services that required in-person meetings or face-to-face interactions.

However, to reduce the impact on profitability, the corporations have shifted their operations to several cost-cutting measures. It also triggered business continuity strategies, such as using analytics and technology to provide remote access, monitoring and Virtual trials in R&D solutions. Market participants also shifted their activities to provide solutions for preventing the spread of the disease, which impacted market growth.

Region-wise Analysis

Which Region Is Expected to Offer the Largest Opportunity for Real World Evidence Solutions Market?

The market in APAC is expected to grow significantly during the forecast period owing to the growing government initiatives for building and implementing the RWE studies backed infrastructure in the healthcare industry. Furthermore, rising demand for better care, rising geriatric population, increasing incidences of chronic illnesses and expansion by global players in the untapped market are the factors driving the demand for Real World Evidence Solutions Market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Analysis

Which Country is the Driving Force behind the growth of the Global real World Evidence Solutions Market?

The United States accounts for the largest revenue share of nearly 30% in the Global Real World Evidence Solutions Market. The U.S. market is anticipated to grow at a CAGR of 11.2% during the forecasted period owing to the growing dominance of RWE service providers in the region and favourable government policies. Furthermore, the region's growth is fuelled by a favourable regulatory environment, a well-established pharmaceutical industry, increased demand for clinical research activities, and expanding research and development spending.

What are the opportunities for U.S., China, Japan and South Korea in Global Real World Evidence Solutions Market?

In terms of CAGR, the U.K. and South Korea grow significantly at a CAGR of 10.7%. This happens because of an increase in government initiatives to implement RWE studies and the presence of numerous contract research organisations (CROs) & manufacturing enterprises. Also, the market is expected to rise due to rising demand for better and affordable healthcare services, increased government efforts to apply RWE research, rising chronic illness burdens, and an increasing geriatric population. Furthermore, China and Japan are expected to grow at a CAGR of 10.5% and 8.8% respectively between 2022 and 2032.

Category-wise Insights

Which component is gaining the utmost traction among the various components?

In 2021, the services segment had the highest revenue share and is expected to grow at a CAGR of 10.4% over the forecasted period. Pharmaceutical and biotechnology businesses which focussed on increasing the adoption of real-world services are the key drivers for this market.

Among data sets segment clinical data, which is either acquired during continuing patient treatment or as part of a formal clinical trial program, is a staple source of most health and medical research. This segment is expected to develop significantly due to an increase in the number of data created in healthcare facilities and the growing demand for new epidemiological insights.

Among applications which segment is expected to show the significant growth potential?

Among the various applications segments considered, the drug development and approvals segment accounted for the highest revenue share with a significant CAGR of 10% during the forecast period. Real World Evidence Solutions services enable pharmaceutical companies, healthcare providers and payers to run operations more efficiently and speed up the development and approval process for medication. As a result, the market for RWE solutions is growing at a CAGR of 10%.

Competitive Analysis

The major corporations in the Global Real World Evidence Solutions market are boosting their research and development expenditure to finance the development of strategically advanced products. Furthermore, government financing, technological developments, regulatory approvals, mergers and acquisitions and diversifying product portfolio has been significantly contributing to the healthy competitive environment. The top players are expected to gain from new product releases and the growth of current operations to maintain their dominance in the global market for Real World Evidence Solutions.

The key competitors in the Real World Evidence Solutions Market are Cegedim Health Data, IBM, Icon Plc., IQVIA, Medpace, Oracle, Parexel International Corp., PerkinElmer, Inc., PPD, Inc., and Syneos Health.

The recent developments in the Global Real World Evidence Solutions Market which were being channelized by market players are as follows:

  • In March 2022, the collaboration between Thermo Fisher and Symphogen has been expanded to include improved data workflow, which aids in the discovery and development of innovative cancer treatments.
  • In January 2022, IQVIA partnered with Argenex SE for accelerating the clinical development of new indications for VYVGART. Furthermore, it will leverage its scientific advice and technology in supporting clinical development by Argenx.
  • In February 2021, IBM begins the second phase of a contract with the National Institutes of Health to develop a verifiable health status reporting and contact tracing system.

Similarly, recent developments related to companies offering Real World Evidence Solutions have been tracked by the team at Future Market Insights, which are available in the full report.

Real World Evidence Solutions Market Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data

2017-2021

Quantitative Units

In US$ Bn

Key Regions Covered

North America, Latin America, Europe, APAC and MEA

Key Countries Covered

United States, China, Japan, South Korea, U.K., Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, India, Australia, South Africa, Saudi Arabia, UAE, Israel

Key Market Segments Covered

Components, Application, End-user and Region

Key Companies Profiled

  • Cegedim Health Data
  • IBM
  • Icon Plc.
  • IQVIA
  • Medpace
  • Oracle
  • Parexel International Corp.
  • PerkinElmer, Inc.
  • PPD, Inc.
  • Syneos Health

Pricing

Available upon Request

Market Segments Covered in Real World Evidence Solutions Market Analysis

By Component:

  • Services
  • Data Sets
    • Clinical Settings Data
    • Claims Data
    • Pharmacy data
    • Patient-powered Data

By Application:

  • Reimbursement/Coverage & Regulatory Decision Making
  • Drug Development & Approvals
  • Medical Device Development & Approvals
  • Post Market Safety & Adverse Events Monitoring

By End-user:

  • Healthcare payers
  • Pharmaceutical & Medical Device Companies
  • Healthcare Providers
  • Other End-users

By Region:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Others
  • APAC
    • India
    • China
    • Japan
    • South Korea
    • Australia
    • Others
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others

Frequently Asked Questions

In 2021, the Global Real World Evidence Solutions Market is worth US$ 39.2 Bn and is estimated to reach US$ 42.8 Bn by the end of 2022.

The Real World Evidence Solutions Market is expected to grow at a CAGR of 10% during the forecasted period of 2022 to 2032. It will be valued at US$ 110 Bn by the end of 2032.

The Real World Evidence Solutions Market provides an absolute dollar opportunity of US$ 67.3 Bn during the period between 2022 and 2032.

The Services component is expected to dominate the market with an expected compound annual growth rate of 10.4% during the forecasted.

The key players operating in the Real World Evidence Solutions market are Cegedim Health Data, IBM, Icon Plc., IQVIA, Medpace, Oracle, Parexel International Corp., PerkinElmer, Inc., PPD, Inc., and Syneos Health.

The U.S. dominates the Global Market for Real World Evidence Solutions with a majority share of around 30%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

4. Global Real World Evidence Solutions Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Component

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Component, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Component, 2022-2032

        5.3.1. Services

        5.3.2. Data Sets

            5.3.2.1. Clinical Settings Data

            5.3.2.2. Claims Data

            5.3.2.3. Pharmacy Data

            5.3.2.4. Patient-Powered Data

    5.4. Y-o-Y Growth Trend Analysis By Component, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Component, 2022-2032

6. Global Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032

        6.3.1. Reimbursement/Coverage & Regulatory Decision Making

        6.3.2. Drug Development & Approvals

        6.3.3. Medical Device Development & Approvals

        6.3.4. Post Market Safety & Adverse Events Monitoring

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022-2032

7. Global Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By End-user

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End-user, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user, 2022-2032

    7.4. Y-o-Y Growth Trend Analysis By End-user, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End-user, 2022-2032

8. Global Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Component

        9.2.3. By Application

        9.2.4. By End-user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Component

        9.3.3. By Application

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Component

        10.2.3. By Application

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Component

        10.3.3. By Application

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. Russia

            11.2.1.7. BENELUX

            11.2.1.8. Rest of Europe

        11.2.2. By Component

        11.2.3. By Application

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Component

        11.3.3. By Application

        11.3.4. By End-user

    11.4. Key Takeaways

12. Asia Pacific Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Rest of Asia Pacific

        12.2.2. By Component

        12.2.3. By Application

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Component

        12.3.3. By Application

        12.3.4. By End-user

    12.4. Key Takeaways

13. MEA Real World Evidence Solutions Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC

            13.2.1.2. Rest of MEA

        13.2.2. By Component

        13.2.3. By Application

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Component

        13.3.3. By Application

        13.3.4. By End-user

    13.4. Key Takeaways

14. Key Countries Real World Evidence Solutions Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Component

            14.1.2.2. By Application

            14.1.2.3. By End-user

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Component

            14.2.2.2. By Application

            14.2.2.3. By End-user

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Component

            14.3.2.2. By Application

            14.3.2.3. By End-user

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Component

            14.4.2.2. By Application

            14.4.2.3. By End-user

    14.5. Argentina

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Component

            14.5.2.2. By Application

            14.5.2.3. By End-user

    14.6. Germany

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Component

            14.6.2.2. By Application

            14.6.2.3. By End-user

    14.7. Italy

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Component

            14.7.2.2. By Application

            14.7.2.3. By End-user

    14.8. France

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Component

            14.8.2.2. By Application

            14.8.2.3. By End-user

    14.9. U.K.

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Component

            14.9.2.2. By Application

            14.9.2.3. By End-user

    14.10. Spain

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Component

            14.10.2.2. By Application

            14.10.2.3. By End-user

    14.11. Russia

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Component

            14.11.2.2. By Application

            14.11.2.3. By End-user

    14.12. BENELUX

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Component

            14.12.2.2. By Application

            14.12.2.3. By End-user

    14.13. China

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Component

            14.13.2.2. By Application

            14.13.2.3. By End-user

    14.14. Japan

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Component

            14.14.2.2. By Application

            14.14.2.3. By End-user

    14.15. South Korea

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Component

            14.15.2.2. By Application

            14.15.2.3. By End-user

    14.16. India

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Component

            14.16.2.2. By Application

            14.16.2.3. By End-user

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Component

            14.17.2.2. By Application

            14.17.2.3. By End-user

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Component

        15.3.3. By Application

        15.3.4. By End-user

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Cegedim Health Data

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segment

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. IBM

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segment

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Icon Plc.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segment

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. IQVIA

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segment

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Medpace

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segment

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Oracle

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segment

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Parexel International Corp.

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segment

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. PerkinElmer, Inc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segment

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. PPD, Inc.

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segment

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Syneos Health

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segment

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Real World Evidence Solutions Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 3: Global Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 4: Global Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Table 5: North America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 7: North America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 8: North America Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Table 9: Latin America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 11: Latin America Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 12: Latin America Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Table 13: Europe Real World Evidence Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 15: Europe Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 16: Europe Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Table 17: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 19: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 20: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Table 21: MEA Real World Evidence Solutions Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Real World Evidence Solutions Market Value (US$ Mn) Forecast by Component, 2017-2032

Table 23: MEA Real World Evidence Solutions Market Value (US$ Mn) Forecast by Application, 2017-2032

Table 24: MEA Real World Evidence Solutions Market Value (US$ Mn) Forecast by End-user, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 2: Global Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 3: Global Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 4: Global Real World Evidence Solutions Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Real World Evidence Solutions Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 9: Global Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 10: Global Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 11: Global Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 12: Global Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 13: Global Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 14: Global Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 15: Global Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 16: Global Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 17: Global Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 18: Global Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 19: Global Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 20: Global Real World Evidence Solutions Market Attractiveness by Region, 2022-2032

Figure 21: North America Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 22: North America Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 23: North America Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 24: North America Real World Evidence Solutions Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 29: North America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 30: North America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 31: North America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 32: North America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 33: North America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 34: North America Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 35: North America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 36: North America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 37: North America Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 38: North America Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 39: North America Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 40: North America Real World Evidence Solutions Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 42: Latin America Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 43: Latin America Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 44: Latin America Real World Evidence Solutions Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 49: Latin America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 50: Latin America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 51: Latin America Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 52: Latin America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 53: Latin America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 54: Latin America Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 55: Latin America Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 56: Latin America Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 57: Latin America Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 58: Latin America Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 59: Latin America Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 60: Latin America Real World Evidence Solutions Market Attractiveness by Country, 2022-2032

Figure 61: Europe Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 62: Europe Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 63: Europe Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 64: Europe Real World Evidence Solutions Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Real World Evidence Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 69: Europe Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 70: Europe Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 71: Europe Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 72: Europe Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 73: Europe Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 74: Europe Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 75: Europe Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 76: Europe Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 77: Europe Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 78: Europe Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 79: Europe Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 80: Europe Real World Evidence Solutions Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 82: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 83: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 84: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 89: Asia Pacific Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 90: Asia Pacific Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 91: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 92: Asia Pacific Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 93: Asia Pacific Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 94: Asia Pacific Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 95: Asia Pacific Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 96: Asia Pacific Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 97: Asia Pacific Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 98: Asia Pacific Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 99: Asia Pacific Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 100: Asia Pacific Real World Evidence Solutions Market Attractiveness by Country, 2022-2032

Figure 101: MEA Real World Evidence Solutions Market Value (US$ Mn) by Component, 2022-2032

Figure 102: MEA Real World Evidence Solutions Market Value (US$ Mn) by Application, 2022-2032

Figure 103: MEA Real World Evidence Solutions Market Value (US$ Mn) by End-user, 2022-2032

Figure 104: MEA Real World Evidence Solutions Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Real World Evidence Solutions Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Real World Evidence Solutions Market Value (US$ Mn) Analysis by Component, 2017-2032

Figure 109: MEA Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Component, 2022-2032

Figure 110: MEA Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Component, 2022-2032

Figure 111: MEA Real World Evidence Solutions Market Value (US$ Mn) Analysis by Application, 2017-2032

Figure 112: MEA Real World Evidence Solutions Market Value Share (%) and BPS Analysis by Application, 2022-2032

Figure 113: MEA Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by Application, 2022-2032

Figure 114: MEA Real World Evidence Solutions Market Value (US$ Mn) Analysis by End-user, 2017-2032

Figure 115: MEA Real World Evidence Solutions Market Value Share (%) and BPS Analysis by End-user, 2022-2032

Figure 116: MEA Real World Evidence Solutions Market Y-o-Y Growth (%) Projections by End-user, 2022-2032

Figure 117: MEA Real World Evidence Solutions Market Attractiveness by Component, 2022-2032

Figure 118: MEA Real World Evidence Solutions Market Attractiveness by Application, 2022-2032

Figure 119: MEA Real World Evidence Solutions Market Attractiveness by End-user, 2022-2032

Figure 120: MEA Real World Evidence Solutions Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Healthcare Interoperability Solutions Market

Published : February 2022

Healthcare

Near-Patient Molecular Solutions Market

Published : November 2016

Healthcare

Pain Therapeutic Solutions Market

Published : February 2016

Healthcare

Hospital Capacity Management Solutions Market

Published : February 2022

Google translate

Real World Evidence Solutions Market